From biomarker discovery to clinical impact, Allotype BioDiscovery supports every step.

We work with leading academic institutions and private companies to accelerate research and develop new therapies.

Our services

Our integrated proteomic solutions bridge the gap between discovery and delivery, enabling faster, smarter and more successful translational science.

We work closely with your team to scope and shape projects at every stage. From discovery and pre-clinical studies to clinical development and regulatory requirements, our team bring deep experience and hands-on support to drive biomarker success and advance precision medicine.

Olink® Proteomics

We provide high throughput protein analysis utilizing cutting-edge Olink® PEA technology. Considered a next-gen proteomics platform, Olink technology enables unparalleled sensitivity and specificity with minimal sample consumption.

Interferon score assay

A precise tool to quantify type I interferon activity to help monitor immune responses and support patient stratification, providing insights in autoimmune and infectious disease research.

Specialist blood processing

Bespoke same-day processing of fresh blood samples available for downstream assays and analysis using strictly validated protocols.

Powered by excellence, driven by quality

UK’s 1st and most experienced Olink Certified Service Provider since 2019

Excellent data quality and customer service

Adherence to GCP standards and robust quality assurance ensures reliable, reproducible data

“Allotype BioDiscovery has been instrumental in helping us analyse samples using the Olink panel for several of our studies. They have been extremely professional in handling new requests, understanding study design and providing suitable recommendations for sample randomisation & plating based on their scientific acumen. It’s been a pleasure working with Allotype BioDiscovery.”

University of Nottingham

Contact us

Email us at [email protected] to see how our services can accelerate and support your research.